Delivery Order SPE2DB24D2109-SPE2DB25FHXPU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,555.23 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,813.65 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg. This competitive, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication, valued at $31,592.78 under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,875.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,299.04 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg on July 28, 2025, with completion expected by July 29, 2025. This competitive award, utilizing firm fixed-price contract terms, represents a small-value pharmaceutical delivery executed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this transaction, which is classified...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,363.70 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed price, non-set-aside delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a product delivery to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $5,562.15 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $27,371.81 to supply NURTEC ODT 75 mg tablets (8-count units) under a firm fixed price contract. The order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive, non-set-aside procurement fulfilled through AmerisourceBergen's existing contract vehicle. Performance will occur at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXPUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,444.01 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 MG, a medication used to treat acute migraine. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract utilizes a non-set-aside procurement vehicle and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves the military healthcare system and related government agencies through this prime IDC, which enables the company to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.4k | 7/31/25 |